Differential effects of predictors of warfarin dose according to race/color categories in the admixed Brazilian population

Pharmacogenet Genomics. 2017 May;27(5):210-211. doi: 10.1097/FPC.0000000000000273.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • African Continental Ancestry Group / genetics
  • Aged
  • Anticoagulants / adverse effects
  • Anticoagulants / pharmacokinetics
  • Anticoagulants / therapeutic use*
  • Brazil
  • Continental Population Groups / genetics
  • Cytochrome P-450 CYP2C9 / genetics*
  • European Continental Ancestry Group / genetics
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Vitamin K Epoxide Reductases / genetics*
  • Warfarin / adverse effects
  • Warfarin / pharmacokinetics
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin
  • Cytochrome P-450 CYP2C9
  • VKORC1 protein, human
  • Vitamin K Epoxide Reductases